Adopting AI requires a thorough, organized, prepared approach for it to best deliver on its plethora of lofty promises. Through the power of knowledge graphs, enterprises can fuel AI strategies with ...

CEO Sam Altman called a strange graph in its GPT-5 presentation a ‘mega chart screwup.’ CEO Sam Altman called a strange graph in its GPT-5 presentation a ‘mega chart screwup.’ is a senior reporter ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

Explore Charles’s Law—in a syringe. Discover the relationship between the temperature and volume of a given amount of gas. Prepare four beakers with four different temperatures of water—some warmer ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...

The latest price target for Cartesian Therapeutics (NASDAQ:RNAC) was reported by Needham on May 8, 2025. The analyst firm set a price target for $40.00 expecting RNAC to rise to within 12 months (a ...

Cartesian Growth Corporation III (the “Company”) announced today the closing of its initial public offering of 27,600,000 units, including 3,600,000 units pursuant to the exercise of the underwriters’ ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

When something as big as the Super Bowl is coming up soon, it can be hard to stay focused. This is especially true for families that are die hard sports fans, or if your city’s team is in the Super ...